One of our main challenges is to promote translational research on chronic non-communicable diseases in the country by providing clinical researchers with valuable preclinical data. This data includes: (i) the detection and identification of early biomarkers and/or new risk factors for complex diseases, and (ii) a comprehensive description of the effects of various molecules—whether natural, synthetic, semi-synthetic, or combinations of these with conventional drugs—on metabolism, cellular redox homeostasis, cell viability, and physiological function in different pathological models.